EN 中文
Home Strategic Partnerships News Contact us
TOTAL:64 NEWS
Zhaoke Ophthalmology Enters Into A Distribution and Supply Agreement With Kwangdong Pharmaceutical To Commercialize NVK002 In South Korea
read
2023-03-28
1839
Zhaoke Ophthalmology Announces 2022 Annual Results
read
2023-03-27
2276
Zhaoke Ophthalmology Commences Commercialisation of its First Drug with Bimatoprost Timolol Eye Drop (晶贝莹®) Obtaining Marketing Authorization from the National Medical Products Administration
read
2023-02-20
2530
Zhaoke Ophthalmology’s Cyclosporine A (CsA) Ophthalmic Gel Passed the Onsite Regulatory and Clinical Trial Inspections by the NMPA, and the GMP Compliance Inspection by the Guangdong Medical Products Administration
read
2023-02-01
1501
兆科眼科荣获第五届粤港澳大湾区生物科技创新企业50强评选“领军企业”奖项
read
2022-12-29
1320
>

Guangzhou Headquarters
Tel: 020-39062828
E-mail: info@zkoph.com
Add: No. 1 Meide 3rd Road, Pearl River Industrial Park, Nansha District, Guangzhou
Hong Kong Headquarters
Tel: (852)23145100
E-mail: info@zkoph.com
Add: Unit 716, 7/F, Building 12W Phase 3, Hong Kong Science Park Shatin, Hong Kong
Wechat
Guangzhou Headquarters
Tel: 020-39062888
E-mail: info@zkoph.com
Add: No. 1 Meide 3rd Road, Pearl River Industrial Park, Nansha District, Guangzhou
Hong Kong Headquarters
Tel: (852)23145100
E-mail: info@zkoph.com
Add: Unit 716, 7/F, Building 12W Phase 3, Hong Kong Science Park Shatin, Hong Kong
Wechat